Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Stack AI Reviews & Ratings
    16 Ratings
    Company Website
  • AWS Step Functions Reviews & Ratings
    102 Ratings
    Company Website
  • PathSolutions TotalView Reviews & Ratings
    42 Ratings
    Company Website
  • RaimaDB Reviews & Ratings
    5 Ratings
    Company Website
  • Windocks Reviews & Ratings
    6 Ratings
    Company Website
  • Google Cloud Platform Reviews & Ratings
    56,321 Ratings
    Company Website
  • TrueCommerce Reviews & Ratings
    924 Ratings
    Company Website
  • Boozang Reviews & Ratings
    15 Ratings
    Company Website
  • D&B Connect Reviews & Ratings
    170 Ratings
    Company Website
  • Amazon EventBridge Reviews & Ratings
    90 Ratings
    Company Website

What is SpliceCore?

Utilizing RNA sequencing (RNA-seq) data in conjunction with Artificial Intelligence offers both an essential need and a remarkable opportunity for developing therapies that target splicing errors. By harnessing machine learning techniques, we can identify new splicing errors and promptly create therapeutic compounds to rectify these issues. Our specialized AI platform, SpliceCore, is dedicated to the discovery of RNA-based therapeutics. This advanced technology excels in analyzing RNA sequencing data with exceptional speed and accuracy. It effectively identifies, assesses, and confirms potential drug targets, surpassing conventional methods in efficiency. A key feature of SpliceCore is our proprietary database, which houses over 5 million potential RNA splicing errors, making it the largest resource of its type worldwide and vital for evaluating any RNA sequencing dataset submitted for analysis. The incorporation of scalable cloud computing enables us to manage extensive RNA sequencing data efficiently and economically, thereby accelerating the development of new therapies. This groundbreaking strategy is set to transform the field of RNA therapeutics, paving the way for unprecedented advancements in treatment options. As we move forward, the potential for discovery in this domain continues to expand, promising a future filled with innovative solutions.

What is Iktos?

Makya emerges as a groundbreaking user-focused SaaS platform specifically tailored for AI-driven de novo drug design, with a particular focus on Multi-Parametric Optimization (MPO). This cutting-edge tool enables users to generate original and easily synthesizable compounds through a multi-objective framework, achieving unparalleled speed, efficiency, and diversity in results. Featuring a variety of generative algorithms that cater to different phases of drug development—from hit discovery to lead optimization—Makya includes a fine-tuning generator for identifying optimal solutions within your defined chemical space, a novelty generator aimed at uncovering new ideas for re-scaffolding and hit identification, and a forward generator that assembles a specialized library of compounds ready for synthesis using commercially accessible starting materials. The platform's latest addition, the Makya 3D module, markedly enhances both the user experience and scientific functionality. With an extensive toolkit of 3D modeling capabilities for both ligand-based and structure-based methodologies, Makya 3D facilitates the computation of 3D scores that can be effortlessly integrated to steer compound generation within the platform. This comprehensive integration not only refines the design workflow but also provides researchers with profound insights into their molecular architectures, ultimately transforming the drug discovery landscape. As researchers increasingly seek innovative solutions, Makya stands at the forefront, revolutionizing the way compounds are designed and developed.

Media

Media

Integrations Supported

Amazon Web Services (AWS)
Google Cloud Platform
Microsoft Azure
Python

Integrations Supported

Amazon Web Services (AWS)
Google Cloud Platform
Microsoft Azure
Python

API Availability

Has API

API Availability

Has API

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

Envisagenics

Date Founded

2014

Company Location

United States

Company Website

www.envisagenics.com/platform/

Company Facts

Organization Name

Iktos

Company Location

France

Company Website

iktos.ai/makya/

Categories and Features

Categories and Features

Popular Alternatives

Popular Alternatives

SILCS Reviews & Ratings

SILCS

SilcsBio
BIOiSIM Reviews & Ratings

BIOiSIM

VERISIMLife
BioNeMo Reviews & Ratings

BioNeMo

NVIDIA
AIDDISON Reviews & Ratings

AIDDISON

Merck KGaA